Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7532639rdf:typepubmed:Citationlld:pubmed
pubmed-article:7532639lifeskim:mentionsumls-concept:C0022131lld:lifeskim
pubmed-article:7532639lifeskim:mentionsumls-concept:C0030281lld:lifeskim
pubmed-article:7532639lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:7532639lifeskim:mentionsumls-concept:C1441616lld:lifeskim
pubmed-article:7532639lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:7532639pubmed:issue5lld:pubmed
pubmed-article:7532639pubmed:dateCreated1995-3-30lld:pubmed
pubmed-article:7532639pubmed:abstractTextEvidence for the presence of peptides, related to insulin-like growth factor 2 (IGF-2), has been obtained in the endocrine pancreas of the elasmobranchian species Raja clavata, the sting ray. By radioimmunoassay, IGF-2-like immunoreactivity was detected in Raja pancreas extract. Further characterization of this activity by acid gel chromatography revealed two distinct peaks of IGF-2-like immunoreactivity with apparent molecular weights of approximately 8.2 kDa and 4.5 kDa. Using the same IGF-2 antibody as well as antisera specific for mammalian IGF-1, insulin, glucagon, somatostatin and pancreatic polypeptide in double immunofluorescence studies, IGF-2-like immunoreactivity was located exclusively in insulin-immunoreactive cells. In contrast, IGF-1-like immunoreactivity was mainly observed in somatostatin- and glucagon-immunoreactive cells. A varying proportion (0-70%) of insulin-immunoreactive cells, however, displayed both IGF-1- and IGF-2-like immunoreactivity. Absorption studies indicated that the IGF-2-like peptides in Raja are different from mammalian and submammalian insulin and mammalian IGF-1, but similar to mammalian IGF-2. Thus, IGF-2-like peptides seem to occur during evolution as early as the phylogenetic development of the elasmobranchians. Furthermore, the results indicate a particularly conservative evolution of the islet IGF-2 system.lld:pubmed
pubmed-article:7532639pubmed:languageenglld:pubmed
pubmed-article:7532639pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7532639pubmed:citationSubsetIMlld:pubmed
pubmed-article:7532639pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7532639pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7532639pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7532639pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7532639pubmed:statusMEDLINElld:pubmed
pubmed-article:7532639pubmed:monthNovlld:pubmed
pubmed-article:7532639pubmed:issn0301-5564lld:pubmed
pubmed-article:7532639pubmed:authorpubmed-author:ReineckeMMlld:pubmed
pubmed-article:7532639pubmed:authorpubmed-author:FalkmerSSlld:pubmed
pubmed-article:7532639pubmed:authorpubmed-author:ShawT JTJlld:pubmed
pubmed-article:7532639pubmed:authorpubmed-author:DrakenbergKKlld:pubmed
pubmed-article:7532639pubmed:authorpubmed-author:WeimarEElld:pubmed
pubmed-article:7532639pubmed:authorpubmed-author:MaakeCClld:pubmed
pubmed-article:7532639pubmed:issnTypePrintlld:pubmed
pubmed-article:7532639pubmed:volume102lld:pubmed
pubmed-article:7532639pubmed:ownerNLMlld:pubmed
pubmed-article:7532639pubmed:authorsCompleteYlld:pubmed
pubmed-article:7532639pubmed:pagination365-71lld:pubmed
pubmed-article:7532639pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7532639pubmed:meshHeadingpubmed-meshheading:7532639-...lld:pubmed
pubmed-article:7532639pubmed:meshHeadingpubmed-meshheading:7532639-...lld:pubmed
pubmed-article:7532639pubmed:meshHeadingpubmed-meshheading:7532639-...lld:pubmed
pubmed-article:7532639pubmed:meshHeadingpubmed-meshheading:7532639-...lld:pubmed
pubmed-article:7532639pubmed:meshHeadingpubmed-meshheading:7532639-...lld:pubmed
pubmed-article:7532639pubmed:meshHeadingpubmed-meshheading:7532639-...lld:pubmed
pubmed-article:7532639pubmed:meshHeadingpubmed-meshheading:7532639-...lld:pubmed
pubmed-article:7532639pubmed:meshHeadingpubmed-meshheading:7532639-...lld:pubmed
pubmed-article:7532639pubmed:meshHeadingpubmed-meshheading:7532639-...lld:pubmed
pubmed-article:7532639pubmed:meshHeadingpubmed-meshheading:7532639-...lld:pubmed
pubmed-article:7532639pubmed:meshHeadingpubmed-meshheading:7532639-...lld:pubmed
pubmed-article:7532639pubmed:meshHeadingpubmed-meshheading:7532639-...lld:pubmed
pubmed-article:7532639pubmed:meshHeadingpubmed-meshheading:7532639-...lld:pubmed
pubmed-article:7532639pubmed:year1994lld:pubmed
pubmed-article:7532639pubmed:articleTitleIGF-2-like peptides are present in insulin cells of the elasmobranchian endocrine pancreas: an immunohistochemical and chromatographic study.lld:pubmed
pubmed-article:7532639pubmed:affiliationInstitute of Anatomy, University of Zürich, Switzerland.lld:pubmed
pubmed-article:7532639pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7532639pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed